Analyst
Ascendiant Capital
Equibles does not estimate personal net worth.
Ed Wu is recorded as Analyst at Ascendiant Capital. Ed Wu has spoken on 16 earnings calls across 8 companies, most recently for Aytu Biopharma, Inc on September 22, 2026. Those appearances were for Travelzoo (TZOO), Aytu Biopharma, Inc (AYTU), Intrusion Inc (INTZ), Genasys Inc. (GNSS), SurgePays, Inc. (SURG) and 3 other companies. The companies whose calls Ed Wu spoke on are classified in the Communication Services, Healthcare and Technology sectors.
“My question is on the sales rep. You mentioned that you were at 43 in March, 32 in July, 42 now. Do you have a goal in mind of where you think you want to be maybe in six months?”
“My question is, is there any change in competitive environment? Thank you.”
“You mentioned that you're going to have a FDA meeting with Port I.O. in the fourth quarter. Do you anticipate, you know, news shortly thereafter? And what do you think of the regulatory pathway may be in 2027?”
“Your line is open. yes thank you for taking my question my question is um the margins on your club members is it uh how profitable it is it and are as you start to add more benefits such as the club access for delayed flights and other benefits is that going to impact your margin for club members the major expense for…”
“Can you maybe comment on kind of interest level you're seeing from physicians, any kind of feedback, et cetera?”
Ascendiant Capital
Analyst
Transcript header (unverified)
TZOO
Internet Content & Information · Communication Services
AYTU
Drug Manufacturers - Specialty & Generic · Healthcare
GNSS
Scientific & Technical Instruments · Technology
INTZ
Software - Infrastructure · Technology
SURG
Telecom Services · Communication Services
PAVM
Medical Devices · Healthcare
